Inflammation, Atrophy, and Gastric Cancer

Overview

Journal J Clin Invest

Specialty General Medicine

Date 2007 Jan 4

PMID 17200707

Citations 381

Authors

James G Fox

Timothy C Wang

Affiliations

Soon will be listed here.

Abstract

The association between chronic inflammation and cancer is now well established. This association has recently received renewed interest with the recognition that microbial pathogens can be responsible for the chronic inflammation observed in many cancers, particularly those originating in the gastrointestinal system. A prime example is Helicobacter pylori, which infects 50% of the world's population and is now known to be responsible for inducing chronic gastric inflammation that progresses to atrophy, metaplasia, dysplasia, and gastric cancer. This Review provides an overview of recent progress in elucidating the bacterial properties responsible for colonization of the stomach, persistence in the stomach, and triggering of inflammation, as well as the host factors that have a role in determining whether gastritis progresses to gastric cancer. We also discuss how the increased understanding of the relationship between inflammation and gastric cancer still leaves many questions unanswered regarding recommendations for prevention and treatment.

Citing Articles

Common occurrence of atrophic gastritis in an ageing non-hospitalised population: an autopsy study.

Karhunen P, Tuomisto S, Goebeler S, Martiskainen M, Kok E Age Ageing. 2025; 54(3).

PMID: 40037561 PMC: 11879357. DOI: 10.1093/ageing/afaf047.

Decoding mitochondrial DNA damage and repair associated with infection.

Shahi A, Kidane D Front Cell Infect Microbiol. 2025; 14:1529441.

PMID: 39906209 PMC: 11790445. DOI: 10.3389/fcimb.2024.1529441.

Clonal hematopoiesis of indeterminate potential is a risk factor of gastric cancer: A Prospective Cohort in UK Biobank study.

Xi Z, Feng H, Chen K, Guo X, Zhu D, Zheng J Transl Oncol. 2024; 52():102242.

PMID: 39675251 PMC: 11713744. DOI: 10.1016/j.tranon.2024.102242.

Machine learning identifies a 5-serum cytokine panel for the early detection of chronic atrophy gastritis patients.

An F, Ge Y, Ye W, Ji L, Chen K, Wang Y Cancer Biomark. 2024; 41(1):25-40.

PMID: 39269824 PMC: 11495322. DOI: 10.3233/CBM-240023.

Non- Gastric Microbiome Modulates Prooncogenic Responses and Is Associated With Gastric Cancer Risk.

Niikura R, Hayakawa Y, Nagata N, Miyoshi-Akiayama T, Miyabayashi K, Tsuboi M Gastro Hep Adv. 2024; 2(5):684-700.

PMID: 39129877 PMC: 11307406. DOI: 10.1016/j.gastha.2023.03.010.

References

Smythies L, Waites K, Lindsey J, Harris P, Ghiara P, Smith P . Helicobacter pylori-induced mucosal inflammation is Th1 mediated and exacerbated in IL-4, but not IFN-gamma, gene-deficient mice. J Immunol. 2000; 165(2):1022-9. DOI: 10.4049/jimmunol.165.2.1022. View

Correa P . Is gastric carcinoma an infectious disease?. N Engl J Med. 1991; 325(16):1170-1. DOI: 10.1056/NEJM199110173251611. View

Shibata A, Parsonnet J, Longacre T, Garcia M, Puligandla B, Davis R . CagA status of Helicobacter pylori infection and p53 gene mutations in gastric adenocarcinoma. Carcinogenesis. 2002; 23(3):419-24. DOI: 10.1093/carcin/23.3.419. View

Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M . Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001; 345(11):784-9. DOI: 10.1056/NEJMoa001999. View

Genta R . Helicobacter pylori, inflammation, mucosal damage, and apoptosis: pathogenesis and definition of gastric atrophy. Gastroenterology. 1997; 113(6 Suppl):S51-5. DOI: 10.1016/s0016-5085(97)80012-1. View

El-Zimaity H, Ota H, Graham D, Akamatsu T, Katsuyama T . Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer. 2002; 94(5):1428-36. DOI: 10.1002/cncr.10375. View

Lee W, Tai D, Lan K, Li A, Hsu H, Lin E . The -251T allele of the interleukin-8 promoter is associated with increased risk of gastric carcinoma featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005; 11(18):6431-41. DOI: 10.1158/1078-0432.CCR-05-0942. View

Whary M, Sundina N, Bravo L, Correa P, Quinones F, Caro F . Intestinal helminthiasis in Colombian children promotes a Th2 response to Helicobacter pylori: possible implications for gastric carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2005; 14(6):1464-9. DOI: 10.1158/1055-9965.EPI-05-0095. View

Houghton J, Stoicov C, Nomura S, Rogers A, Carlson J, Li H . Gastric cancer originating from bone marrow-derived cells. Science. 2004; 306(5701):1568-71. DOI: 10.1126/science.1099513. View

10.

Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T . Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002; 99(22):14428-33. PMC: 137900. DOI: 10.1073/pnas.222375399. View

11.

Parsonnet J, Friedman G, ORENTREICH N, Vogelman H . Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut. 1997; 40(3):297-301. PMC: 1027076. DOI: 10.1136/gut.40.3.297. View

12.

Furuta T, Shirai N, Sugimoto M . Controversy in polymorphisms of interleukin-1beta in gastric cancer risks. J Gastroenterol. 2004; 39(5):501-3. DOI: 10.1007/s00535-004-1353-6. View

13.

Li Q, Karam S, Gordon J . Diphtheria toxin-mediated ablation of parietal cells in the stomach of transgenic mice. J Biol Chem. 1996; 271(7):3671-6. View

14.

Schwizer W, Thumshirn M, Dent J, Guldenschuh I, Menne D, Cathomas G . Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial. Lancet. 2001; 357(9270):1738-42. DOI: 10.1016/S0140-6736(00)04894-7. View

15.

Correa P . Clinical implications of recent developments in gastric cancer pathology and epidemiology. Semin Oncol. 1985; 12(1):2-10. View

16.

Semino-Mora C, Doi S, Marty A, Simko V, Carlstedt I, Dubois A . Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma. J Infect Dis. 2003; 187(8):1165-77. PMC: 2569196. DOI: 10.1086/368133. View

17.

Vaira D, Vakil N, Rugge M, Gatta L, Ricci C, Menegatti M . Effect of Helicobacter pylori eradication on development of dyspeptic and reflux disease in healthy asymptomatic subjects. Gut. 2003; 52(11):1543-7. PMC: 1773848. DOI: 10.1136/gut.52.11.1543. View

18.

Jordan C, Guzman M, Noble M . Cancer stem cells. N Engl J Med. 2006; 355(12):1253-61. DOI: 10.1056/NEJMra061808. View

19.

Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R . Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003; 301(5636):1099-102. DOI: 10.1126/science.1086871. View

20.

Parkin D, Pisani P, Ferlay J . Global cancer statistics. CA Cancer J Clin. 1999; 49(1):33-64, 1. DOI: 10.3322/canjclin.49.1.33. View